Publications

5440 Results

Combined modality treatment of advanced Hodgkin's disease: Southwest Oncology Group studies In:

Authors
CA Coltman Jr;E Frei III;E Montague;PN Grozea;EJ DePersio;CJ Fabian;CM Mansfield;SE Jones;DO Dixon
Journal / Conference
In: Management of Advanced Cancer P Periman, E Savlov eds. Masson Publishing USA 79-111
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7406, SWOG-7518

Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group study

Authors
SE Jones;PN Grozea;EN Metz;A Haut;RL Stephens;FS Morrison;R Talley;JJ Butler;GE Byrne;R Hartsock;D Dixon;SE Salmon
Journal / Conference
Cancer 51:1083-1090
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7426/7427

The combined modality therapy of diffuse histology non- Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation

Authors
JK Weick;A Antunez;TA Kraus;CJ Fabian;D Dixon
Journal / Conference
Int J Rad Oncol Biol Phys 9:1205-1207
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7761

Methyl-glyoxal bis guanyl hydrazone (Methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group

Authors
WA Knight III;C Fabian;JJ Costanzi;SE Jones;CA Coltman Jr
Journal / Conference
Investigational New Drugs 1:235-237
Year
1983
Research Committee(s)
Multiple sites
Study Number(s)
SWOG-7860

Gallium Nitrate in malignant lymphoma: A Southwest Oncology Group study

Authors
JK Weick;RL Stephens;LH Baker;SE Jones
Journal / Conference
Cancer Treat Rep 67:823-825
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7912

Phase II study of Amsacrine (m-AMSA) in advanced lymphomas: A Southwest Oncology Group study

Authors
JK Weick;SE Jones;DH Ryan
Journal / Conference
Cancer Treat Rep 67:489-492
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7918

Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease (HD): A Southwest Oncology Group Phase II study

Authors
TP Miller;SE Jones;JM Rainey
Journal / Conference
Cancer Treat Rep 67:739-740
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7961

Mitoxantrone hydrochloride (NSC-301739) in lymphoma. A Southwest Oncology Group study

Authors
CA Coltman Jr;TM McDaniel;SP Balcerzak;FS Morrison;DD Von Hoff
Journal / Conference
Investigational New Drugs 1:065-070
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8005

Mitoxantrone hydrochloride in lymphoma

Authors
CA Coltman Jr;TM McDaniel;SP Balcerzak;FS Morrison;DD Von Hoff
Journal / Conference
In: 13th International Congress of Chemotherapy (Vienna, August 28-Sepember 2, 1983). KH Spitzy, K Karrer, eds. Symposium Mitoxantrone 212:52-55
Year
1983
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8005

Mitoxantrone hydrochloride in hematologic malignancies: Southwest Oncology Group Phase II studies.

Authors
CA Coltman Jr;JH Saiki;FJ Panettiere;SP Balcerzak;RL Stephens;FS Morrison;DO Dixon;DD Von Hoff
Journal / Conference
In: 3rd NCI-EORTC Symposium on New Drugs in Cancer Therapy (Brussels, October 15-17, 1981) M Rozencweig, DD Von Hoff, MJ Staquet, eds. New Anticancer Drugs: Mitoxantrone and Bisantrene. New York: Raven Press 115-124.
Year
1983
Research Committee(s)
Leukemia and Lymphoma
Study Number(s)
SWOG-8005, SWOG-8032